Arun J. Sanyal - Concepedia

Author

Arun J. Sanyal

Also Known As

A J Sanyal, A SANYAL, A Sanyal, A. J. SANYAL, A. J. Sanyal, A. Sanyal, A.J. SANYAL, A.J. Sanyal, ARUN J SANYAL, ARUN J. SANYAL

1.4K

Publications

148.2K

Citations

166

H-Index

312

Concepts

All Affiliations

Virginia Commonwealth University Virginia Commonwealth University Medical Center University of California San Diego Indiana University – Purdue University Indianapolis Indiana University School of Medicine

About

Arun J. Sanyal is an author at Virginia Commonwealth University specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	82	190	46.8K
2	Health Sciences	52	90	29.9K
3	Business	1	1	124
4	Engineering	1	1	93
5	Language Studies	1	1	397

Arun J. Sanyal

503

Publications

101.5K

Citations

141

H-Index

Page 1

	Year	Citations
Design and validation of a histological scoring system for nonalcoholic fatty liver disease† David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta, Hepatology Nafld Activity ScoreDiagnosisPathologyGastroenterologyFatty Liver Disease	2005	10.5K
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Hepatology	2012	3.8K
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley, New England Journal of Medicine	2010	3.2K
A multisociety Delphi consensus statement on new fatty liver disease nomenclature Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Hepatology Evidence-based MedicinePathologyFatty Liver DiseaseObesityMetabolic Syndrome	2023	2.5K
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal, The Lancet HepatologyMedicineLiver PhysiologyPathologyPlacebo-controlled Trial	2014	2.2K
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities Arun J. Sanyal, Carol Campbell–Sargent, Faridoddin Mirshahi, Gastroenterology ObesityMetabolic SyndromeInsulin ResistanceMetabolic Associated SteatohepatitisHepatology	2001	2.1K
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 Chris Estes, Quentin M. Anstee, M. Arias, Journal of Hepatology	2018	1.9K
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Gastroenterology ObesityMetabolic SyndromePractice GuidelineMetabolic Associated SteatohepatitisHepatology	2012	1.8K
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi, New England Journal of Medicine	2020	1.7K
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis Guadalupe García–Tsao, Arun J. Sanyal, Norman D. Grace, Hepatology	2007	1.7K

Page 1